Details of the Drug

General Information of Drug (ID: DMUU3KJ)

Drug Name
FX-006
Indication
Disease Entry ICD 11 Status REF
Pain MG30-MG3Z Phase 3 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C24H31FO6
Canonical SMILES
CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C
InChI
InChI=1S/C24H31FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h7-9,15-17,19,26,28H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1
InChIKey
YNDXUCZADRHECN-JNQJZLCISA-N
Cross-matching ID
PubChem CID
6436
ChEBI ID
CHEMBL71418
CAS Number
76-25-5
TTD ID
D08YWK
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 ClinicalTrials.gov (NCT02357459) Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee. U.S. National Institutes of Health.